摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-amino-α-(E-methoxyimino)-4-thiazoleacetate hydrobromide | 69689-85-6

中文名称
——
中文别名
——
英文名称
ethyl 2-amino-α-(E-methoxyimino)-4-thiazoleacetate hydrobromide
英文别名
ethyl (E)-α-(2-aminothiazol-4-yl)-α-metoxyiminoacetate hydrobromide;ethyl 2-methoxyimino-2-(2-amino-1,3-thiazol-4-yl)acetate hydrobromide;ethyl 2-methoxyimino-2-(2-aminothiazol-4-yl)acetate hydrobromide;ethyl (2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetate;hydrobromide
ethyl 2-amino-α-(E-methoxyimino)-4-thiazoleacetate hydrobromide化学式
CAS
69689-85-6
化学式
BrH*C8H11N3O3S
mdl
——
分子量
310.172
InChiKey
HVJCFGLFQGEABA-ICSBZGNSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    溶于甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    1.22
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    115
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Syn-isomers of
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US04279818A1
    公开(公告)日:1981-07-21
    New syn-isomers of 3-cephem-4-carboxylic acids having anti-bacterial activities, processes for preparation thereof, pharmaceutical compositions thereof, with the acids being substituted at the 3 position with acyloxymethyl, hydroxymethyl, formyl or heterocyclic thiomethyl groups and at the 7 position with alkoxyiminoacetamido substituted with substituted phenyl or substituted thiazolyl.
    具有抗菌活性的3-头孢菌素-4-羧酸的新同构体,其制备方法,药物组合物,其中酸在3位被醋氧甲基,羟甲基,甲酰基或杂环甲基基团取代,并且在7位被烷氧基亚胺基取代的取代苯基或取代噻唑基取代。
  • Syn 7-oxoimino substituted derivatives of cephalosporanic acid
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US04166115A1
    公开(公告)日:1979-08-28
    The present invention relates to new syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and pharmaceutically acceptable salts thereof. More particularly, it relates to new syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and pharmaceutically acceptable salts thereof which have antibacterial activities and to processes for the preparation thereof, to pharmaceutical composition comprising the same, and to a method of using the same therapeutically in the treatment of infectious diseases in human beings and animals.
    本发明涉及3,7-二取代-3-头孢烯-4-羧酸化合物的新的同构体及其药用盐。更具体地说,涉及具有抗菌活性的新的3,7-二取代-3-头孢烯-4-羧酸化合物的同构体及其药用盐,以及其制备方法、包含其的药物组合物,以及在人类和动物的传染病治疗中治疗使用的方法。
  • 2-Lower alkyl-7-substituted-2 or 3-cephem 4-carboxylic acid compounds
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US04299829A1
    公开(公告)日:1981-11-10
    Compounds of the formula: ##STR1## wherein R.sup.1 is (C.sub.1 to C.sub.6) alkyl. R.sup.2 is carboxy or a protected carboxy group, R.sup.3 is amino or a protected amino group and A is hydroxyimino (C.sub.1 to C.sub.6) alkylene or (C.sub.1 to C.sub.6)-alkoxyimino (C.sub.1 to C.sub.6) alkylene, and pharmaceutically acceptable salt thereof, have been found to be active against various pathogenic microorganisms.
    公式为:##STR1## 其中R.sup.1为(C.sub.1至C.sub.6)烷基。R.sup.2为羧基或受保护的羧基,R.sup.3为基或受保护的基,A为羟基(C.sub.1至C.sub.6)烷基或(C.sub.1至C.sub.6)烷氧基(C.sub.1至C.sub.6)烷基,以及其药学上可接受的盐,已发现对各种致病微生物具有活性。
  • 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US04152433A1
    公开(公告)日:1979-05-01
    A compound of the formula: ##STR1## wherein R.sup.1 is (C.sub.1 to C.sub.6) alkyl, R.sup.2 is a carboxy or a protected carboxy group, R.sup.3 is amino or a protected amino group and A is hydroxyimino (C.sub.1 to C.sub.6) alkylene or (C.sub.1 to C.sub.6)-alkoxyimino (C.sub.1 to C.sub.6)alkylene, And pharmaceutically acceptable salt thereof.
    一个化合物的化学式为:##STR1## 其中R.sup.1是(C.sub.1到C.sub.6)烷基,R.sup.2是羧基或保护羧基,R.sup.3是基或保护基,A是羟基亚胺(C.sub.1到C.sub.6)烷基或(C.sub.1到C.sub.6)-烷氧基亚胺(C.sub.1到C.sub.6)烷基,以及其药用可接受的盐。
  • US4152433A
    申请人:——
    公开号:US4152433A
    公开(公告)日:1979-05-01
查看更多